Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Tirzepatide is a dual agonist that combines: GLP-1 (glucagon-like peptide-1) activity GIP (glucose-dependent insulinotropic polypeptide) activity This combination creates a stronger incretin effect, improving insulin sensitivity and appetite control more effectively than GLP-1 medications alone
Unlike traditional clinical-trials, SURMOUNT-REAL will evaluate tirzepatide in routine care settings, tracking outcomes across diverse populations and health systems
A slower digestion process also reduces spikes in blood sugar, which can be linked to overeating
Billings LK, Handelsman Y, Heile M, Schneider D, Wyne K
:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)
US$ 26.91
US$ 23.40
US$ 24.82
